Papers by Elliott M. Antman
Page 3 · newest first
- Evaluating the Cardiovascular Safety of Nonsteroidal Anti-Inflammatory DrugsCirculation · 2017
- Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 TrialJournal of the American College of Cardiology · 2017
- Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic ValvesCirculation · 2017
- Stroke and Mortality Risk in Patients With Various Patterns of Atrial FibrillationCirculation Arrhythmia and Electrophysiology · 2017
- A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trialEuropean Heart Journal · 2016
- Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial FibrillationJAMA Cardiology · 2016
- Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial InfarctionCirculation · 2016
- Management of Bleeding With Non–Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal AgentsCirculation · 2016
- Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular EventsStroke · 2016
- Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF‐TIMI 48 TrialJournal of the American Heart Association · 2016
- Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 TrialCirculation · 2016
- Efficacy and Safety of Edoxaban Compared with Warfarin in Patients with Atrial Fibrillation and Heart Failure: Insights from ENGAGE AF-TIMI 48European Journal of Heart Failure · 2016
- Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 TrialSHILAP Revista de lepidopterología · 2016
- Evidence-Based Policy Making: Assessment of the American Heart Association’s Strategic Policy PortfolioCirculation · 2016
- Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 TrialThe American Journal of Medicine · 2016
- Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 TrialJournal of the American Heart Association · 2016
- Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the LandscapeJournal of the American Heart Association · 2015
- Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trialEuropean Heart Journal · 2015
- Workplace Wellness Recognition for Optimizing Workplace HealthCirculation · 2015
- Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation†European Heart Journal · 2015
- Fibrinolysis Use Among Patients Requiring Interhospital Transfer for ST-Segment Elevation Myocardial Infarction CareJAMA Internal Medicine · 2014
- Edoxaban Effects on Bleeding Following Punch Biopsy and Reversal by a 4-Factor Prothrombin Complex ConcentrateCirculation · 2014
- Sustainable Development Goals and the Future of Cardiovascular Health: A Statement From the Global Cardiovascular Disease TaskforceJournal of the American Heart Association · 2014
- Sustainable Development Goals and the Future of Cardiovascular Health: A Statement From the Global Cardiovascular Disease TaskforceGlobal Heart · 2014
- Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus WarfarinStroke · 2014
- Stakeholder Discussion to Reduce Population-Wide Sodium Intake and Decrease Sodium in the Food SupplyCirculation · 2014
- Clinical Practice Guidelines for Chronic Cardiovascular Disorders: A Roadmap for the FutureJAMA · 2014
- Patterns of Long‐term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI ‐38 Coronary Stent RegistryClinical Cardiology · 2014
- Data sharing in research: benefits and risks for cliniciansBMJ · 2014
- The 50th Anniversary of the US Surgeon General's Report on Tobacco: What We've Accomplished and Where We Go From HereJournal of the American Heart Association · 2014
- Clinical Research and the Development of Medical TherapeuticsCirculation Journal · 2014
- Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48European Heart Journal · 2013
- Edoxaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine · 2013
- Circadian Variation of Stent Thrombosis and the Effect of More Robust Platelet InhibitionJournal of Cardiovascular Pharmacology and Therapeutics · 2013
- Prognostic Performance of a High-Sensitivity Cardiac Troponin I Assay in Patients with Non–ST-Elevation Acute Coronary SyndromeClinical Chemistry · 2013
- Full Prescription Coverage Versus Usual Prescription Coverage After Coronary Artery Bypass Graft SurgeryCirculation · 2013
- Bypassing the Emergency Department to Improve the Process of Care for ST-Elevation Myocardial InfarctionCirculation · 2013
- 2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial InfarctionCirculation · 2013
- Dynamic TIMI Risk Score for STEMIJournal of the American Heart Association · 2013
- Synthesis, Grading, and Presentation of Evidence in Guidelines: Article 7 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop ReportProceedings of the American Thoracic Society · 2012
- Transforming Clinical Trials in Cardiovascular DiseaseJAMA · 2012
- Circadian Variation in Patient Characteristics and Outcomes in ST-Segment Elevation Myocardial InfarctionChronobiology International · 2012
- Sodium, Blood Pressure, and Cardiovascular DiseaseCirculation · 2012
- Third universal definition of myocardial infarctionEuropean Heart Journal · 2012
- Acute Hyperkalemia Detected by Alert from Implantable Cardioverter‐DefibrillatorPacing and Clinical Electrophysiology · 2012
- Systems of Care for ST-Segment–Elevation Myocardial Infarction: A Report From the American Heart Association’s Mission: LifelineCirculation Cardiovascular Quality and Outcomes · 2012
- Systems pharmacology, pharmacogenetics, and clinical trial design in network medicineWIREs Systems Biology and Medicine · 2012
- Modelling and simulation of edoxaban exposure and response relationships in patients with atrial fibrillationThrombosis and Haemostasis · 2012
- American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation Universal Definition of Myocardial Infarction Classification System and the Risk of Cardiovascular DeathCirculation · 2011
- Full Coverage for Preventive Medications after Myocardial InfarctionNew England Journal of Medicine · 2011